Genovis AB (publ.) (STO:GENO)
Sweden · Delayed Price · Currency is SEK 23.05
+0.55 (2.44%)
Oct 31, 2025, 12:59 PM CET
Genovis AB (publ.) Revenue
Genovis AB (publ.) had revenue of 29.05M SEK in the quarter ending June 30, 2025, a decrease of -2.30%. This brings the company's revenue in the last twelve months to 123.19M, down -3.85% year-over-year. In the year 2024, Genovis AB (publ.) had annual revenue of 131.32M, down -17.44%.
Revenue (ttm)
123.19M
Revenue Growth
-3.85%
P/S Ratio
12.36
Revenue / Employee
3.62M
Employees
32
Market Cap
1.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.32M | -27.75M | -17.44% |
| Dec 31, 2023 | 159.07M | 55.51M | 53.60% |
| Dec 31, 2022 | 103.56M | 9.89M | 10.55% |
| Dec 31, 2021 | 93.68M | 32.65M | 53.49% |
| Dec 31, 2020 | 61.03M | 480.58K | 0.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |
Genovis AB (publ.) News
- 1 year ago - Genovis AB (OSTO:GENO) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus